BioSenic S.A. (BIOS.BR)

EUR 0.0

(0.0%)

Operating Expenses Summary of BioSenic S.A.

BioSenic S.A.'s latest annual operating expenses in 2023 was 7.58 Million EUR , up 227.14% from previous year.
BioSenic S.A.'s latest quarterly operating expenses in 2024 Q2 was 1.58 Million EUR , down 0.0% from previous quarter.
BioSenic S.A. reported a annual operating expenses of 2.31 Million EUR in annual operating expenses 2022, down -82.2% from previous year.
BioSenic S.A. reported a annual operating expenses of 13.02 Million EUR in annual operating expenses 2021, down -18.67% from previous year.
BioSenic S.A. reported a quarterly operating expenses of 1.58 Million EUR for 2024 Q1, down -4.73% from previous quarter.
BioSenic S.A. reported a quarterly operating expenses of 7.34 Million EUR for 2023 FY, up 217.0% from previous quarter.

Annual Operating Expenses Chart of BioSenic S.A. (2023 - 2012)

Historical Annual Operating Expenses of BioSenic S.A. (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	7.58 Million EUR	227.14%
2022	2.31 Million EUR	-82.2%
2021	13.02 Million EUR	-18.67%
2020	16.01 Million EUR	43.34%
2019	11.17 Million EUR	-10.36%
2018	12.46 Million EUR	1.06%
2017	12.33 Million EUR	-3.63%
2016	12.79 Million EUR	4.7%
2015	12.22 Million EUR	117.32%
2014	5.62 Million EUR	39.09%
2013	4.04 Million EUR	10.43%
2012	3.66 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	1.58 Million EUR	0.0%
2024 Q1	1.58 Million EUR	-4.73%
2023 FY	7.34 Million EUR	217.0%
2023 Q1	10.16 Million EUR	925.33%
2023 Q2	4.16 Million EUR	-59.01%
2023 Q3	1.67 Million EUR	-59.74%
2023 Q4	1.65 Million EUR	-1.07%
2022 Q4	990.99 Thousand EUR	0.0%
2022 FY	2.31 Million EUR	-82.2%
2022 Q3	990.99 Thousand EUR	-76.64%
2022 Q2	4.24 Million EUR	0.0%
2021 Q4	8.2 Million EUR	0.0%
2021 FY	13.02 Million EUR	-18.67%
2021 Q2	6.43 Million EUR	0.0%
2020 Q4	8.54 Million EUR	0.0%
2020 FY	16.01 Million EUR	43.34%
2020 Q2	9.78 Million EUR	0.0%
2019 FY	11.17 Million EUR	-10.36%
2019 Q2	6.72 Million EUR	0.0%
2019 Q4	7.01 Million EUR	0.0%
2018 Q4	8.29 Million EUR	0.0%
2018 FY	12.46 Million EUR	1.06%
2017 FY	12.33 Million EUR	-3.63%
2016 FY	12.79 Million EUR	4.7%
2015 FY	12.22 Million EUR	117.32%
2014 Q3	1.08 Million EUR	0.0%
2014 FY	5.62 Million EUR	39.09%
2014 Q4	1.88 Million EUR	73.75%
2013 Q4	1.31 Million EUR	0.0%
2013 FY	4.04 Million EUR	10.43%
2012 FY	3.66 Million EUR	0.0%

Peer Operating Expenses Comparison of BioSenic S.A.

Name	Operating Expenses	Operating Expenses Difference
Nicox S.A.	-11.5 Million EUR	165.922%
European Medical Solutions	13.64 Million EUR	44.435%
FERMENTALG	12.34 Million EUR	38.569%
argenx SE	1.34 Billion EUR	99.435%
Celyad Oncology SA	8.49 Million EUR	10.683%
Hyloris Pharmaceuticals SA	17.98 Million EUR	57.842%
Onward Medical N.V.	20.64 Million EUR	63.27%
Oxurion NV	12.21 Million EUR	37.916%
PHAXIAM Therapeutics S.A.	24.98 Million EUR	69.651%
Financière de Tubize SA	114.38 Thousand EUR	-6529.134%
UCB SA	2.94 Billion EUR	99.742%